Pharsight

Nuvo Pharms Inc patents expiration

1. Pennsaid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8217078 NUVO PHARMS INC Treatment of pain with topical diclofenac
Jul, 2029

(5 years from now)

US8618164 NUVO PHARMS INC Treatment of pain with topical diclofenac compounds
Jul, 2029

(5 years from now)

US8741956 NUVO PHARMS INC Treatment of pain with topical diclofenac
Jul, 2029

(5 years from now)

US8546450 NUVO PHARMS INC Treatment of pain with topical diclofenac compounds
Aug, 2030

(6 years from now)

Drugs and Companies using DICLOFENAC SODIUM ingredient

Market Authorisation Date: 04 November, 2009

Treatment: Use of topical diclofenac on the knee and a second topical medication on the same knee; Use of topical diclofenac on the knee and a second topical prescription medication on the same knee; Combination...

Dosage: SOLUTION;TOPICAL

How can I launch a generic of PENNSAID before it's drug patent expiration?
More Information on Dosage

PENNSAID family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic